ANNOUNCEMENTS
   Excellent performance in Academic, Co-curricular and extracurricular activities               Personal Counseling Committee for identifying the difficulties of students            
Shri Vishweshwar Shikshan Prasarak Mandal Almala

SHIVLINGESHWAR COLLEGE OF PHARMACY

Almala Tq-Ausa, Dist-Latur, Maharashtra, India
Approved by Pharmacy Council of India, New Delhi.
Recognised by Director of Technical Education, Mumbai.
Affiliated to : Swami Ramanand Teerth Marathwada University, Nanded-431606,(Maharashtra).
Contact Us
+91 9342 428 080,
+91 9405 750 000
Email Us at
scop.pharmacy@gmail.com
S.No Doccument
1 Anti Descrimination Cell 2021-22 VIEW
2 Anti Ragging Committee 2021-22 VIEW
3 Gender Sensitization Cell 2021-22 (2) VIEW
4 Training & Placement Cell VIEW
5 Result Summer 2021 (B Pharm) VIEW
6 Result Summer 2021 (Pharm D) VIEW
7 B. Pharmacy Time Table 2021-22 VIEW
8 PCI SIF VIEW
9 Under Prime Minister's Special Scholarship Scheme (PMSSS) Admitted Students for J & K and Ladakh VIEW
10 Prime Minister's Special Scholarship Scheme (PMSSS) Pamphlet VIEW
11 Prime Minister's Special Scholarship Scheme (PMSSS) Brochure VIEW
12 J& K , LADAKH ADMISSION AY 2022-23 Round 1 Revised Calendar VIEW
13 8th National Level Poster & Model Presentation Contest” VIEW
14 B Pharm Direct Second Year Vacant Seat Admission Notification for 2022-23 VIEW
15 FFRA INCOME AND EXPENSES 2023-24 VIEW
16 FRA FACULTY SALARY- 2023-24 VIEW
17 CALCULATION SHEET M PHARM- 2023-24 VIEW
18 CALCULATION SHEET B PHARM- 2023-24 VIEW
19 CALCULATION SHEET PHARM D- 2023-24 VIEW
20 FRA INSTITUTE INFORMATION - 2023-24 VIEW
21 FRA PAYMENT RECEIPT 2023-24 VIEW
22 D PHARM VACANCY 2022-23 VIEW
23 Against CAP & Institute Level Seat Advertisement 2022-23 VIEW
24 VACANCY AFTER CAP ROUND III (ACAP AND INSTITUTE LEVEL SEAT) 2022-23 B PHARM AND PHARM D VIEW
25 Vacant seats after CAP Round for Admission to M. PHARM & Pharm. D. (Post Baccalaureate) for the Academic Year 2022-23. VIEW
26 National Institutional Ranking Framework- Report VIEW
27 IIQA-Statutory Declaration under Section 4 (1) (b) of Right to information Act-2005 VIEW
28 GRIEVANCE COMMITTEE 2022-23 VIEW